Insider: Norry Elliot Chief Medical Officer - Adaptimmune Therapeutics PLC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 7,510 | 0 | 7,510 |
| Value | $1,120.49 | $0.00 | $1,120.49 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/17/2025 | DDS | 5,584 | Direct | COM | $0.58 | $3,243.19 | 7,510 |
| 01/15/2025 | DDS | 9,803 | Direct | COM | $0.57 | $5,634.76 | 13,756 |
| 01/13/2025 | DDS | 4,268 | Direct | COM | $0.59 | $2,509.16 | 5,845 |
| 01/13/2025 | DDS | 8,124 | Direct | COM | $0.59 | $4,776.10 | 11,516 |
| 01/17/2024 | DDS | 5,309 | Direct | COM | $0.67 | $3,572.96 | 7,785 |
| 01/17/2024 | DDS | 12,967 | Direct | COM | $0.67 | $8,726.79 | 19,257 |
| 01/16/2024 | DDS | 2,287 | Direct | COM | $0.79 | $1,806.73 | 3,363 |
| 01/12/2024 | DDS | 7,799 | Direct | COM | $0.85 | $6,661.13 | 11,841 |
| 01/11/2024 | DDS | 4,009 | Direct | COM | $0.84 | $3,354.33 | 6,104 |
| 01/17/2023 | DDS | 2,159 | Direct | COM | $1.86 | $4,011.42 | 3,491 |
| 01/12/2023 | DDS | 7,449 | Direct | COM | $1.71 | $12,707.99 | 12,191 |
| 01/11/2023 | DDS | 3,843 | Direct | COM | $1.75 | $6,712.95 | 6,270 |
| 01/04/2023 | DDS | 876 | Direct | COM | $1.69 | $1,483.94 | 1,361 |
| 01/18/2022 | DDS | 2,121 | Direct | COM | $3.19 | $6,769.81 | 3,529 |
| 01/12/2022 | DDS | 854 | Direct | COM | $3.54 | $3,026.66 | 1,383 |
| 01/11/2022 | DDS | 3,770 | Direct | COM | $3.56 | $13,408.76 | 6,343 |
| 01/04/2022 | DDS | 849 | Direct | COM | $4.06 | $3,450.51 | 1,388 |
| 01/19/2021 | DDS | 2,111 | Direct | COM | $5.67 | $11,968.31 | 3,539 |
| 01/12/2021 | DDS | 841 | Direct | COM | $6.15 | $5,174.00 | 1,396 |
| 01/04/2021 | DDS | 845 | Direct | COM | $5.33 | $4,502.08 | 1,392 |
| 01/14/2020 | DDS | 911 | Direct | COM | $5.13 | $4,677.71 | 1,326 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research